These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 34206708)

  • 1. Renin-Angiotensin System in Pathogenesis of Atherosclerosis and Treatment of CVD.
    Poznyak AV; Bharadwaj D; Prasad G; Grechko AV; Sazonova MA; Orekhov AN
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34206708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the renin-angiotensin-aldosterone system and proinflammatory mediators in cardiovascular disease.
    Ferrario CM; Strawn WB
    Am J Cardiol; 2006 Jul; 98(1):121-8. PubMed ID: 16784934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypertension: renin-angiotensin-aldosterone system alterations.
    Te Riet L; van Esch JH; Roks AJ; van den Meiracker AH; Danser AH
    Circ Res; 2015 Mar; 116(6):960-75. PubMed ID: 25767283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of the renin angiotensin aldosterone system: focus on aliskiren.
    Rao MS
    J Assoc Physicians India; 2010 Feb; 58():102-8. PubMed ID: 20653151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the renin-angiotensin-aldosterone system in the pathogenesis of atherosclerosis.
    Durante A; Peretto G; Laricchia A; Ancona F; Spartera M; Mangieri A; Cianflone D
    Curr Pharm Des; 2012; 18(7):981-1004. PubMed ID: 22283771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does reversal of oxidative stress and inflammation provide vascular protection?
    Koh KK; Oh PC; Quon MJ
    Cardiovasc Res; 2009 Mar; 81(4):649-59. PubMed ID: 19098298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Inflammation and atherosclerosis: the role of Renin-Angiotensin system and its inhibition].
    Partigulova AS; Naumov VG
    Kardiologiia; 2010; 50(10):50-5. PubMed ID: 21118180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methods in the evaluation of cardiovascular renin angiotensin aldosterone activation and oxidative stress.
    Manrique C; Lastra G; Habibi J; Wei Y; Morris EM; Stump CS; Sowers JR
    Methods Mol Med; 2007; 139():163-79. PubMed ID: 18287671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The blockade of renin-angiotensin-aldosterone system in hemodialysis patients to control hypertension and prevent cardiovascular disease: optimal pharmacotherapy.
    Morishita Y; Kusano E
    Cardiovasc Hematol Agents Med Chem; 2011 Oct; 9(4):241-6. PubMed ID: 22023537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on RAAS Modulation for the Treatment of Diabetic Cardiovascular Disease.
    Bernardi S; Michelli A; Zuolo G; Candido R; Fabris B
    J Diabetes Res; 2016; 2016():8917578. PubMed ID: 27652272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pathophysiological role of tissue renin-angiotensin-aldosterone system (RAAS) in human atherosclerosis].
    Fukui K; Yamada H; Matsubara H
    Nihon Rinsho; 2012 Sep; 70(9):1556-61. PubMed ID: 23012803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of the renin-angiotensin-aldosterone-system on cardiovascular and renal complications in diabetes mellitus.
    Hayashi T; Takai S; Yamashita C
    Curr Vasc Pharmacol; 2010 Mar; 8(2):189-97. PubMed ID: 19485896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of the renin-angiotensin-aldosterone system for the secondary prevention of stroke.
    Sokol SI; Portnay EL; Curtis JP; Nelson MA; Hebert PR; Setaro JF; Foody JM
    Neurology; 2004 Jul; 63(2):208-13. PubMed ID: 15277610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The renin-angiotensin-aldosterone system as a target in coronary disease.
    O'Keefe JH; Lurk JT; Kahatapitiya RC; Haskin JA
    Curr Atheroscler Rep; 2003 Mar; 5(2):124-30. PubMed ID: 12573198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The evolving landscape of RAAS inhibition: from ACE inhibitors to ARBs, to DRIs and beyond.
    Epstein BJ; Leonard PT; Shah NK
    Expert Rev Cardiovasc Ther; 2012 Jun; 10(6):713-25. PubMed ID: 22894628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal and cardio-protective effects of direct renin inhibition: a systematic literature review.
    Lambers Heerspink HJ; Perkovic V; de Zeeuw D
    J Hypertens; 2009 Dec; 27(12):2321-31. PubMed ID: 19727007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The renin-angiotensin system modulates inflammatory processes in atherosclerosis: evidence from basic research and clinical studies.
    Montecucco F; Pende A; Mach F
    Mediators Inflamm; 2009; 2009():752406. PubMed ID: 19390623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of renin-angiotensin-aldosterone system-blocking drugs on peritoneal membrane in peritoneal dialysis patients.
    Trošt Rupnik A; Pajek J; Guček A; Osredkar J; Kovač D; Bren A; Klančič D; Saksida S; Rus I; Globokar M; Drozg A; Lešnik M; Plešivčnik Z; Ekart R; Lopert S; Lindič J
    Ther Apher Dial; 2013 Aug; 17(4):425-30. PubMed ID: 23931884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Critical role of renin-angiotensin system in the pathogenesis of atherosclerosis].
    Hirata Y; Fukuda D; Sata M
    Nihon Rinsho; 2011 Jan; 69(1):55-9. PubMed ID: 21226261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of the Renin-Angiotensin system mediates the effects of dietary salt intake on atherogenesis in the apolipoprotein E knockout mouse.
    Tikellis C; Pickering RJ; Tsorotes D; Huet O; Chin-Dusting J; Cooper ME; Thomas MC
    Hypertension; 2012 Jul; 60(1):98-105. PubMed ID: 22647892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.